2nd Circ. Eyes BMS $30M Suit Over Mylan's Sale Of AIDS Drug
The Second Circuit appeared poised Tuesday to revive Bristol-Myers Squibb Co.'s $30 million breach of contract suit against Mylan Laboratories Ltd. over Mylan's alleged unlawful sale of a patented Bristol-Myers AIDS...To view the full article, register now.
Already a subscriber? Click here to view full article